Can Healthcare Stocks Continue to Outperform?…Update-2 Recap Q3 and September
Update-2 Healthcare and Biotech Recap September Our strategic focus has been large cap biopharmaceuticals and healthcare (mainly UNH). Smaller caps have been a disappointment except for traders.The IWM is down 10% in one month! Some of our speculative picks are still in the green since JY 1...
Rayno BioBeat 2022 Looking For A Q4 Rally in Life Science Stocks…Update-2
Update-2 ...9/22...3P EDT--Healthcare stocks trying to hold up: XLV up 0.69% up from recent lows of $122. NASDAQ down 1.62%. Weak sectors Consumer Discretionary, Financials , Industrials, Large cap biopharma and HC strong: ABBV, BMY, JNJ, MRK,PFE, REGN, LLY. UNH up 1.24% at $518. Biotechs weak...
Healthcare Sector Still Looks Good But Lacks Momentum…Update-3 Nice Biotech Rally!
9/12/22...Bristol-Myers (BMY) up 5% on FDA approval of psoriasis drug.Large cap biopharmas rally: AZN, GILD, MRK, etc. Mid- caps green esp MDGL,MRTX. Morgan Stanley Healthcare conference was today could account for biotech strength. Biden Issues Executive Order on Advancing Biotechnology. Time...
Whither Small Caps after FED’s Tough Talk? Update-1…Aug 31
Update-1 Third Day this week of flailing around in the red, even AAPL down 1%. Small cap winners: EVH,MRTX, QDEL speculative ETFs: ARKG up 1.31%, XBI up 0.72% at $83.70 IBB flat at $121.46, XLV down 0.64% at $124.76. Notable biotech movers: CYTK up 3.78% at $52.96, IOVA up 2.585 at $10.72.MDGL...
Large Cap Biopharmaceutical Metrics as of Q2 earnings 2022…Update-2 9/1…Biopharmas rally
9/1/22. Biopharmaceuticals rally...another choppy session with aa last hour rally bringing Dow and S&P in the green. Strength in ABBV, REGN,PFE, LLY, VRTX. check them out vs chart below; AZN and GSK are weak. XLV up 1.64% to $126.81. Technician are looking at 390 for key technical level...